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ABSTRACT
A total of 2,576 steers allotted to 24 
pens were used to evaluate 2 forms of 
ractopamine, Optaflexx (Elanco Animal 
Health, Greenfield, IN) or Actogain 45 
(Zoetis, Florham Park, NJ) brands of 
ractopamine hydrochloride, on steer 
performance and carcass traits (12 pens; 
1,288 steers per treatment). Both test ar-
ticles were fed at a rate of 16.4 g/t (DM 
basis) to target a consumption of 210 mg 
per head for an average (range 28 to 31) 
of 30 d. Total gain, daily gain, and feed 
efficiency tended (P < 0.10) to favor 
Actogain 45 on a live basis. However, 
there were no significant differences (P 
≥ 0.32) between treatments for carcass-
adjusted total gain, daily gain, or feed 
efficiency. Furthermore, there were no 
differences for estimated total carcass 
gain or rate of carcass gain (P ≥ 0.34). 
Finally, there were no differences (P ≥ 
0.29) in HCW or any carcass USDA YG 
or QG variables. There was no evidence 
of lameness or locomotion impairment in 
any steer during the course of this study 
or at time of slaughter. It was con-
cluded there were no differences between 
Optaflexx and Actogain 45 on perfor-
mance or carcass traits of steers when 
fed at a rate of 16.4 g/t (DM basis) for 
the final 30 d on feed.
Key words: ractopamine hydrochlo-
ride, beta-agonist, beef cattle
INTRODUCTION
Ractopamine hydrochloride is 
an orally active phenethanolamine 
β1-adrenergic agonist that is fed in 
commercial finishing yards as a means 
to repartition dietary energy toward 
lean tissue accretion and away from 
adipose tissue deposition (Moody 
et al., 2000). Several studies have 
reported improved ADG, G:F, final 
BW, and carcass weight when admin-
istering ractopamine in finishing diets 
(Avendaño-Reyes et al., 2006; Gruber 
et al., 2007; Winterholler et al., 2007). 
The β-agonist Optaflexx (ractopamine 
hydrochloride) has been available 
for use by the United States feedlot 
industry for finishing beef cattle since 
2004, with indications for increased 
rate of weight gain, improved feed 
efficiency, and increased carcass lean-
ness when fed at a rate of 90 to 430 
mg per steers per day. In addition 
to improvements observed in finish-
ing performance, Winterholler et al. 
(2007) observed an increase of 8 kg of 
HCW and an increase of 1.74 cm2 (P 
= 0.08) of LM area. Concurrent with 
increased carcass weight and rib-eye 
area, Winterholler et al. (2007) re-
ported decreased marbling scores rela-
tive to animals not fed ractopamine, 
as did Gruber et al. (2007).
A generic equivalent to Optaflexx 
(Actogain 45) was approved for use in 
United States beef cattle in 2013. The 
objective of this study was to evaluate 
commercial bioequivalence between 
the 2 commercial ractopamine hydro-
chloride products fed at a rate of 16.4 
g/t (DM basis) for the final 30 d on 
feed as measured by rate of weight 
gain, feed efficiency, and carcass traits 
of steers.
MATERIALS AND METHODS
A total of 2,576 British and Brit-
ish–Continental cross steers ran-
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domly allotted to 24 pens were used 
to compare the effects of Optaflexx 
(Elanco Animal Health, Greenfield, 
IN) or Actogain 45 (Zoetis, Florham 
Park, NJ) on performance and carcass 
traits. The study was conducted at 
a commercial feedlot near Pasco, 
Washington. All personnel at the 
feedlot were beef quality assurance 
trained. Animals that were identified 
as study candidates were received ap-
proximately 110 to 130 d before study 
initiation. Steers were weighed at ar-
rival and averaged approximately 404 
± 29 kg. All cattle were implanted 
with Revalor-IS (80 mg of trenbolone 
acetate and 16 mg estradiol; Merck 
Animal Health, Summit, NJ) implant 
at arrival and then again approxi-
mately 70 d before slaughter with 
Revalor-200 (200 mg of trenbolone 
acetate and 20 mg estradiol; Merck 
Animal Health). All candidate steers 
received Pyramid 5 [antigens for bo-
vine rhinotracheitis, bovine virus diar-
rhea (Types I and II), bovine para-
influenza-3, and bovine respiratory 
syncytial virus; Boehringer Ingelheim 
Vetmedica Inc., St. Joseph, MO] viral 
vaccine at arrival and were processed 
with Dectomax (1 mL/50 kg of BW; 
doramectin, Zoetis) injectable solu-
tion and Valbazen (10 mL/113 kg of 
BW; albendazole; Zoetis) suspension 
for parasite control. All methods of 
processing and products used were 
similar and distributed evenly across 
all candidate pens before study initia-
tion. Diets containing 34 g/t (DM 
basis) of monensin sodium (Rumen-
sin 80, Elanco Animal Health) and 
8 g/t (DM basis) of tylosin (Tylosin 
40, Elanco Animal Health) were fed 
before the initiation of the study. 
Pretrial finishing diets were similar to 
finishing diets. During the ractopa-
mine study period each diet contained 
34 g/t (DM basis) monensin sodium 
and 8 g/t (DM basis) of tylosin in ad-
dition to 16.4 g/t (DM basis) of either 
Optaflexx or Actogain 45 to target 
approximately 210 mg/d per steer of 
study product. Animals were handled 
according to standard National Cat-
tlemen’s Beef Association beef quality 
assurance guidelines regarding animal 
welfare. Candidate steers for each 
replicate consisted of steers that had 
been fed together in a single pen (n 
= 197 to 246) before initiation of the 
study. On day zero of the ractopamine 
feeding period, steers were removed, a 
pen at a time, from their original pen. 
Steers were then gate cut 4 steers at 
a time and allocated to 1 of 2 treat-
ment pens. Treatment designation 
for each of the resulting paired pens 
was randomly assigned via coin flip. 
Each pair of treatment pens originat-
ing from one larger pen served as a 
replicate. This process was repeated 
until all 12 replicates were filled. On 
days where more than one replicate 
was enrolled in the study, the first 
replicate was enrolled while subse-
quent replicates of cattle remained in 
their home pens until they could be 
allotted. The study was initiated on 
July 23, 2014, and slaughter of the 
final replicate was completed October 
24, 2014 (Table 1). The final study 
period for all replicates was 28 to 31 
d on feed. The number of steers per 
final study pen ranged from 98 to 123. 
Pens were 2,062 m2, providing 16.7 to 
20.8 m2 of pen space and 23.1 to 28.4 
cm of bunk space per steer, depend-
ing on the replicate. Average diet 
composition (dry basis) during the 
course of the study was 60.7% steam-
flaked corn, 11.0% high-moisture corn, 
10.0% wet distillers grains, 4% alfalfa 
hay, 6.7% corn silage, and 4.3% liquid 
supplement. Diets were formulated to 
meet or exceed NRC (1996) nutrient 
requirements. All candidate cattle 
were fed a common ration through-
out the finishing period before study 
initiation. Diets were manufactured in 
a central location of the feedyard and 
were mixed in a stationary mixer and 
delivered via feed trucks. Test ar-
ticles were distributed equally across 
all diets and fed throughout the day 
during the 3 feedings. Feed deliver-
ies occurred via 3 evenly distributed 
feedings throughout the day. Bunks 
were observed at approximately 0600 
h, and adjustments were made to 
each bunk daily such that only trace 
amounts of the previous day’s ra-
tion remained. Feed refusals were 
controlled by bunk management with 
feed calls being cut accordingly if 
any feed was remaining in the bunk. 
Dietary DM was measured daily in a 
forced-air laboratory oven at 100°C 
for 24 h. Mean weekly dietary DM 
values were used to calculate DMI.
The test articles were administered 
via a microingredient machine (Ani-
mal Health International, Greeley, 
CO). Actogain 45 and Optaflexx were 
fed at a rate of 16.4 g/t (DM basis) 
to provide approximately 210 mg per 
steer of active ingredient.
Complete replicates were slaugh-
tered on the same day at a com-
mercial packing facility near Pasco, 
Washington. Pens within each repli-
cate were group weighed early in the 
Table 1. Replicate information
Replicate
Head enrolled, 
No. Day zero1  Slaughter date Days on feed
1 197 July 23 August 22 30
2 222 July 23 August 22 30
3 199 July 23 August 22 30
4 222 July 23 August 22 30
5 246 August 5 September 5 31
6 200 August 12 September 10 29
7 213 September 9 October 11 31
8 228 September 9 October 11 31
9 212 September 16 October 14 28
10 200 September 16 October 14 28
11 224 September 23 October 24 31
12 213 September 23 October 24 31
1Study initiation date. Study conducted in 2014.
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morning, shipped, and slaughtered 
that same day. Feedlot personnel 
followed the trucks to the plant on 
each slaughter date to ensure that 
pen integrity was maintained through 
the slaughter process. Carcass data 
obtained from kill sheets obtained 
from the packing plant included HCW 
as well as USDA QG and YG data for 
each pen. Initial and final BW were 
calculated as gross live BW adjusted 
by a 4% shrink. Carcass-adjusted BW 
were calculated for each replicate as 
HCW divided by the average DP for 
that replicate. Live and carcass-ad-
justed performance variables were cal-
culated only on a deads and removed 
animals excluded basis, as only one 
animal originally enrolled in the study 
did not complete the study.
Performance and carcass data were 
analyzed using the Mixed Models 
procedure (SAS Institute Inc., Cary, 
NC). Pen served as the experimental 
unit. Treatment was the fixed effect 
and replicate was the random effect 
for each variable. Standard error of 
the mean and F ratios were calculated 
for each variable. Nonparametric mor-
bidity and mortality data were first 
converted to rank using the NPAR-
1WAY procedure (SAS Institute Inc.). 
Rankings were then subjected to 
ANOVA.
RESULTS AND DISCUSSION
There was no difference (P = 0.88) 
in DMI between treatments (Table 2). 
Steers fed Actogain 45 tended (P < 
0.10) to gain faster and more efficient-
ly than those fed Optaflexx on a live 
basis. However, on a carcass-adjusted 
basis, there were no differences (P = 
0.32) between treatments for total 
BW gain or ADG. Carcass-adjusted 
final BW were calculated as HCW 
divided by average DP for both pens 
comprising the replicate.
Carcass weight gain was estimated 
in this study (Table 2). Initial carcass 
weights were calculated as initial live 
BW multiplied by a DP of 0.62. This 
value was derived by modification 
of an equation developed by P. T. 
Anderson (2014, Midwest PMS, Fire-
stone, CO, personal communication) 
and has been used in previous experi-
ments with ractopamine (Quinn et 
al., 2008). There were no differences 
between treatments in estimated total 
carcass gain (P = 0.32) or rate of 
carcass gain (P = 0.33).
Hot carcass weights (Table 3) aver-
aged 416 kg and did not differ (P = 
0.55) between treatments. Similarly, 
DP did not differ (P = 0.45) between 
treatments, averaging 63.3%. Percent-
age of carcasses grading USDA Choice 
and Prime averaged 87% and did not 
differ (P = 0.29). Furthermore, there 
was no difference between treatments 
in YG distribution.
Table 2. Treatment effects on performance of steers fed ractopamine as 
either Optaflexx (Elanco Animal Health, Greenfield, IN) or Actogain 45 
(Zoetis, Florham Park, NJ)
Item Optaflexx Actogain 45 SE P-value
Number of pens 12 12   
Number of steers 1,288 1,288   
Initial BW,1 kg 596 593 3.8 0.14
Final BW,1 kg 657 656 4.8 0.69
Carcass-adjusted final BW,2 kg 657 656 4.9 0.54
Days on feed3 30 30   
DMI, kg 11.65 11.65 0.205 0.88
Live performance     
 Total BW gain, kg 60.5 62.7 1.68 0.056
 ADG, kg 2.00 2.09 0.047 0.06
 G:F 0.172 0.179 0.011 0.054
Carcass-adjusted performance     
 Total BW gain, kg 60.9 62.3 1.77 0.32
 ADG, kg 2.03 2.08 0.051 0.32
 G:F 0.174 0.178 0.012 0.44
Estimated total carcass gain,4 kg 46.4 47.3 0.91 0.34
Estimated carcass gain,4 kg/d 1.55 1.58 0.028 0.335
1Gross live weight multiplied by 0.96.
2Hot carcass weight divided by the average DP for the replicate.
3Range of 28 to 31 d, depending on the replicate.
4Initial carcass weight calculated as initial live BW multiplied by 0.62.
Table 3. Treatment effects on carcass traits of steers fed ractopamine 
as either Optaflexx (Elanco Animal Health, Greenfield, IN) or Actogain 
45 (Zoetis, Florham Park, NJ)
Item Optaflexx Actogain 45 SE P-value
HCW, kg 416 415 2.8 0.55
DP 63.37 63.28 0.130 0.45
USDA QG     
 Prime, % 0.8 1.1 0.45 0.26
 Choice, % 87.0 85.1 2.61 0.35
 Select, % 11.6 13.7 2.39 0.19
 Standard, % 0.6 0.1 0.42 0.19
USDA YG     
 YG 1, % 4.5 4.1 1.09 0.67
 YG 2, % 32.0 32.0 2.82 0.97
 YG 3, % 53.2 53.2 2.83 0.98
 YG 4 and 5, % 10.4 10.7 1.67 0.68
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There was no difference (P = 
0.98, Table 4) in number of animals 
treated during this study. All steers 
treated were diagnosed with respira-
tory disorder (subjectively assessed 
via feedlot personnel following typical 
yard standard operating procedures) 
or atypical interstitial pneumonia 
symptoms. One steer died during the 
course of this study. That death was 
attributed to bloat. There were no 
steers removed from the study, and 
because only one steer died (and it 
could not be attributed to treatment) 
and no steers were removed, a “deads 
and removed animals in” analysis was 
not done. All animals that started the 
study finished the study, except one 
mortality. No animals were removed 
from the study as a result of lameness 
or impaired locomotion.
Although total BW gain, ADG, and 
feed efficiency numerically favored 
Actogain 45 on a live basis, there 
were no differences between treat-
ments for carcass-adjusted perfor-
mance variables. Furthermore, there 
were no differences for estimated total 
carcass gain or rate of carcass gain. 
Finally, there were no differences for 
any carcass variables. It is therefore 
concluded there were no differences 
between Optaflexx and Actogain 
45 when evaluating performance or 
carcass traits of steers fed at a rate 
of 16.4 g/t (DM basis) ractopamine 
hydrochloride to target a consumption 
of 210 mg per steer.
IMPLICATIONS
Actogain 45 proved to be equivalent 
to Optaflexx with respect to effects 
on rate of weight gain, efficiency of 
weight gain, carcass weight, estimated 
carcass weight gain, carcass qual-
ity and YG variables. Results of this 
study confirm equivalence between 
the products in a commercial research 
setting that more closely resembles 
true production settings. Results of 
this study combined with studies 
submitted to the United States Food 
and Drug AdministrationA by Zoetis 
for approval of Actogain 45 indicate 
there is little need for further research 
to prove bioequivalence of the 2 prod-
ucts.
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